Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN FINANCIAL GROUP INCAFG · Entity 743 | Director | June 01, 2021 | June 02, 2021 |
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | Director | May 01, 2026 | May 04, 2026 |
| MYRIAD GENETICS INCMYGN · Entity 5953 | President Assurex Health | September 14, 2016 | September 16, 2016 |
| SIGNET JEWELERS LTDSIG · Entity 8824 | Director · Chief Executive Officer | October 15, 2024 | October 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN FINANCIAL GROUP INC
Report date June 01, 2021 · Filed June 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,619 |
Reported balance
After 2021-06-01 transaction · row 1
1 source rowRow 1 · 2021-06-01 · Grant · Acquired 1,131 · Balance 12,619 F1: Represents a grant of restricted stock issued under the Company's Non-Employee Director's Compensation Plan. |
| Common StockSEC Table I · non-derivative | IndirectDRIP | 93.809 |
Reported balance
Holding disclosure · report date 2021-06-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 93.809 F2: Shares held under the Company's dividend reinvestment plan as of December 31, 2020 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock issued under the Company's Non-Employee Director's Compensation Plan.
F2: Shares held under the Company's dividend reinvestment plan as of December 31, 2020
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,434 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Exercise / conversion · Acquired 2,335 · Balance 2,434 F1: Represent RSUs granted under the Non-Employee Director Compensation Program. F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-05-01 | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Exercise / conversion · Disposed 2,335 · Balance 0 F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F1: Represent RSUs granted under the Non-Employee Director Compensation Program. F3: On July 1, 2025, the reporting person was granted 2,335 restricted stock units, all of which vested on May 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represent RSUs granted under the Non-Employee Director Compensation Program.
F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.
F3: On July 1, 2025, the reporting person was granted 2,335 restricted stock units, all of which vested on May 1, 2026.
MYRIAD GENETICS INC
Report date September 14, 2016 · Filed September 16, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
After 2016-09-14 transaction · row 1
1 source rowRow 1 · 2016-09-14 · Grant · Acquired 50,000 · Balance 50,000 F1: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.
SIGNET JEWELERS LTD
Report date October 15, 2024 · Filed October 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, par value $0.18SEC Table I · non-derivative | Direct | 678,820 |
Last balance in matching sequence
After 2024-10-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2024-10-15 · Sale · Disposed 600 · Balance 728,220 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on June 14, 2024 for investment diversification purposes. F2: The price reported is the weighted average price of multiple trades at prices ranging from $101.25 to $101.26. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range. F3: Includes 123,214 restricted stock units which are subject to certain vesting and forfeiture provisions. Row 2 · 2024-10-16 · Sale · Disposed 41,206 · Balance 687,014 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on June 14, 2024 for investment diversification purposes. F4: The price reported is the weighted average price of multiple trades at prices ranging from $101.25 to $102.24. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range. F3: Includes 123,214 restricted stock units which are subject to certain vesting and forfeiture provisions. Row 3 · 2024-10-16 · Sale · Disposed 8,194 · Balance 678,820 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on June 14, 2024 for investment diversification purposes. F5: The price reported is the weighted average price of multiple trades at prices ranging from $102.25 to $102.45. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range. F3: Includes 123,214 restricted stock units which are subject to certain vesting and forfeiture provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into in good faith by the Reporting Person on June 14, 2024 for investment diversification purposes.
F2: The price reported is the weighted average price of multiple trades at prices ranging from $101.25 to $101.26. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range.
F3: Includes 123,214 restricted stock units which are subject to certain vesting and forfeiture provisions.
F4: The price reported is the weighted average price of multiple trades at prices ranging from $101.25 to $102.24. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range.
F5: The price reported is the weighted average price of multiple trades at prices ranging from $102.25 to $102.45. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the reported range.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FOOT LOCKER, INC.
Report date September 08, 2025 · Filed September 08, 2025
Section 16 reporting ended · disclosed 2025-09-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,647 |
Reported balance
After 2025-09-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-09-08 · Disposition to issuer · Disposed 3,551 · Balance 19,647 F1: On September 8, 2025, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated May 15, 2025, by and among DICK'S Sporting Goods, Inc., a Delaware corporation ("Parent"), RJS Sub LLC, a New York limited liability company and a wholly owned direct Subsidiary of Parent ("Merger Sub"), and the Issuer, the Issuer became a wholly owned subsidiary of Parent (the "Merger"). F2: At the effective time of the Merger (the "Effective Time"), each time-based restricted stock unit ("RSU") of the Issuer held by a non-employee director of the Issuer that is outstanding as of immediately prior to the Effective Time, whether or not vested, was cancelled and converted into the right to receive, without interest, an amount in cash equal to (i) the number of shares of Issuer common stock subject to such Issuer RSU as of immediately prior to the Effective Time multiplied by (ii) $24.00. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-09-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-09-08 · Disposition to issuer · Disposed 19,647 · Balance 0 F3: At the Effective Time, pursuant to the Merger Agreement and subject to certain exceptions, each share of Issuer common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, without interest and at the holder's election, either (i) an amount in cash equal to $24.00 or (ii) 0.1168 shares of Parent common stock (except that any fractional shares were instead replaced by the right to receive a corresponding cash amount). |
Filing footnotes · ownership attribution and instrument terms
F1: On September 8, 2025, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated May 15, 2025, by and among DICK'S Sporting Goods, Inc., a Delaware corporation ("Parent"), RJS Sub LLC, a New York limited liability company and a wholly owned direct Subsidiary of Parent ("Merger Sub"), and the Issuer, the Issuer became a wholly owned subsidiary of Parent (the "Merger").
F2: At the effective time of the Merger (the "Effective Time"), each time-based restricted stock unit ("RSU") of the Issuer held by a non-employee director of the Issuer that is outstanding as of immediately prior to the Effective Time, whether or not vested, was cancelled and converted into the right to receive, without interest, an amount in cash equal to (i) the number of shares of Issuer common stock subject to such Issuer RSU as of immediately prior to the Effective Time multiplied by (ii) $24.00.
F3: At the Effective Time, pursuant to the Merger Agreement and subject to certain exceptions, each share of Issuer common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, without interest and at the holder's election, either (i) an amount in cash equal to $24.00 or (ii) 0.1168 shares of Parent common stock (except that any fractional shares were instead replaced by the right to receive a corresponding cash amount).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2016 Filed Sep 16, 2016 18:29 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001554969-16-000003 · edgardoc.xml · nonDerivative · entry 1 Drosos Virginia · CIK 0001554969 · President Assurex Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.